Back to search

United States· US:87063-049_4ca4b03b-efbe-4d32-e063-6394a90af0f3

Hydrocodone Bitartrate and Acetaminophen

A medicinal product containing hydrocodone bitartrate; acetaminophen, registered in United States by Asclemed USA, Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedHydrocodone Bitartrate and Acetaminop…ATC—REGISTER NO.US:87063-049_4ca4b03b…PACKS LISTED18CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
HYDROCODONE BITARTRATE; ACETAMINOPHEN
Manufacturer
Asclemed USA, Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 18

  • ndc11
    8706304901
    100 TABLET in 1 BOTTLE (87063-049-01)
  • ndc11
    8706304905
    5 TABLET in 1 BOTTLE (87063-049-05)
  • ndc11
    8706304907
    7 TABLET in 1 BOTTLE (87063-049-07)
  • ndc11
    8706304910
    10 TABLET in 1 BOTTLE (87063-049-10)
  • ndc11
    8706304914
    14 TABLET in 1 BOTTLE (87063-049-14)
  • ndc11
    8706304920
    20 TABLET in 1 BOTTLE (87063-049-20)
  • ndc11
    8706304930
    30 TABLET in 1 BOTTLE (87063-049-30)
  • ndc11
    8706304960
    60 TABLET in 1 BOTTLE (87063-049-60)
  • ndc11
    8706304990
    90 TABLET in 1 BOTTLE (87063-049-90)
  • ndc11
    87063-049-01
  • ndc11
    87063-049-05
  • ndc11
    87063-049-07
  • ndc11
    87063-049-10
  • ndc11
    87063-049-14
  • ndc11
    87063-049-20
  • ndc11
    87063-049-30
  • ndc11
    87063-049-60
  • ndc11
    87063-049-90

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a89d937f-2b56-42bd-9cc1-5f7b4521b7a8
GET /v1/drugs/a89d937f-2b56-42bd-9cc1-5f7b4521b7a8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "5; 325",
  "substance": "HYDROCODONE BITARTRATE; ACETAMINOPHEN",
  "productndc": "87063-049",
  "dosage_form": "TABLET",
  "dea_schedule": "CII",
  "strength_unit": "mg/1; mg/1",
  "application_number": "ANDA210211",
  "marketing_category": "ANDA"
}

See everything about hydrocodone bitartrate; acetaminophen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.